Fierce Pharma

MARCH 22, 2024

Sales are booming for Novo Nordisk’s GLP-1 treatments for diabetes and obesity. But that doesn’t mean the Danish company has moved on from its previous generation of blood sugar modulators. | With a positive recommendation from Europe’s Committee for Medicinal Products for Human Use (CHMP), Novo has come a step closer to bringing its revolutionary Awiqli (once weekly basal insulin icodec) to the market.

Medicine 321

Medicine Sales Marketing 321

MedCity News

MARCH 22, 2024

Today, new digital solutions are emerging that provide tailored exercise programs and encourage small changes to daily life that can lead to significantly lower fall risk.

Leads 119

Leads 119

Fierce Pharma

MARCH 22, 2024

At a watershed moment for Duchenne muscular dystrophy (DMD) treatment, privately held Italian drugmaker Italfarmaco has added a new therapeutic option to the armamentarium against the debilitating | At a watershed moment for Duchenne muscular dystrophy treatment, privately held Italian drugmaker Italfarmaco has added a new therapeutic option to the armamentarium against the debilitating muscle-wasting disorder.

FDA 307

FDA 307

MedCity News

MARCH 22, 2024

A CPO in the C-suite determines how a health system can move from a cost center to a revenue center with healthy operating margins by investing in specialty pharmacy services that reduce burden for healthcare staff and improve care for patients.

Healthcare 119

Healthcare Healthcare Patients 119

Advertisement

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

Sales Management

Fierce Pharma

MARCH 22, 2024

At a time of heightened geopolitical tensions between the U.S. and China, Eli Lilly’s CEO said the Indianapolis-based company remains committed to the Chinese market. | David Ricks’ visit to China comes as Lilly has several key drug applications under review at local regulators.

Marketing 298

Marketing 298

MedCity News

MARCH 22, 2024

Corticosteroids are a standard first-line treatment for Duchenne muscular dystrophy, but these drugs have many side effects. FDA approval of Italfarmaco’s Duvyzat is the first nonsteroidal drug to pass the agency’s regulatory bar for treating this rare disease.

Side effects 119

Side effects FDA Patients Biopharma 119

MedCity News

MARCH 22, 2024

During a panel at HIMSS, three health system leaders explained what digital transformation means to them and how they’re seeking it play out at their organizations.

Medical 116

Medical Healthcare Healthcare 116

pharmaphorum

MARCH 22, 2024

Italfarmaco’s non-steroidal drug Duvyzat (givinostat) has been approved in the US as a treatment for Duchenne muscular dystrophy (DMD)

FDA 111

FDA 111

MedCity News

MARCH 22, 2024

Collaboration across key stakeholders, including home health agencies, providers, patients, health plans, and post-acute care solution providers will be critical to fully enabling the home as a preferred place of care.

Patients 112

Patients Healthcare Healthcare 112

Pharmaceutical Technology

MARCH 22, 2024

The EMA CHMP has recommended marketing authorisation for Novo Nordisk's Awiqli for treating diabetes in adult patients.

Marketing 105

Marketing Patients 105

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patients

MedCity News

MARCH 22, 2024

Humana and DUOS have partnered to launch a new program that supports Humana’s Louisiana veteran seniors with a chronic condition. These veterans will be connected to DUOS, which can address their health-related social needs.

106

106

pharmaphorum

MARCH 22, 2024

Medicare has loosened restrictions on the reimbursement of obesity drugs, thanks to clinical data showing they can improve cardiovascular outcomes, but their price could be up for negotiation.

105

105

Pharmaceutical Commerce

MARCH 22, 2024

In an interview with Pharma Commerce Associate Editor Don Tracy, Amy Niles, Chief Mission Officer, The PAN Foundation discusses the overall mission of the organization.

Pharma 105

Pharma 105

PM360

MARCH 22, 2024

AI-driven healthcare is making its way into our lives and with it comes positive changes Imagine a world where my AI emails your AI and they join forces to schedule our coffee chat. Next thing you know, we’re discussing campaign strategies over lattes, courtesy of our digital matchmakers. Welcome to the future, where AI in healthcare marketing isn’t just a concept— it’s the new normal.

Healthcare 104

Healthcare Healthcare Marketing Patients 104

Advertisement

Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten

Sales

pharmaphorum

MARCH 22, 2024

Idorsia Pharmaceuticals has claimed FDA approval for aprocitentan as a treatment for resistant hypertension, becoming the first drug in the endothelin receptor antagonist class for that indication.

FDA 104

FDA Pharmaceutical 104

PM360

MARCH 22, 2024

It is with immense sadness that I write this. A one of a kind, loyal, and generous friend and mentor. I will miss his humor, unrivaled intelligence, guidance, wisdom—and I can’t leave out his fashion sense, especially those killer shoes. Rest in peace my very dear friend.

98

98

pharmaphorum

MARCH 22, 2024

It has been a bumper week for biotech financings, with a $400m Series A for Mirador heading, topping impressive rounds for Capstan, Clasp, Engrail, Enliven, and Nouscom.

104

104

PharmaTimes

MARCH 22, 2024

Dementia is estimated to affect 850,000 people in the UK and costs the nation around £23bn a year

97

97

Advertisement

Pharmaceutical Technology

MARCH 22, 2024

The US FDA has granted ODD to HI-Bio's felzartamab to treat antibody-mediated rejection (AMR) in kidney transplant recipients.

FDA 97

FDA 97

PharmaTimes

MARCH 22, 2024

These types of conditions are responsible for 25% of all UK deaths and affect 7.

97

97

European Pharmaceutical Review

MARCH 22, 2024

Research suggests that combining ribociclib with hormone therapy improved invasive-free survival in stage 2 or 3 HR-positive, HER2-negative early breast cancer. The study data showed that distant disease-free survival and recurrence-free survival improved when the small molecule CDK4/6 inhibitor ribociclib was used alongside a nonsteroidal aromatase inhibitor (NSAI).

Medicine 97

Medicine Patients Pharmaceutical 97

Pharmacy Times

MARCH 22, 2024

As more states have legalized cannabis use—both medicinal and recreational—Sera said pharmacists’ roles in counseling will become even more important.

Patients 61

Patients Medicine 61

Advertisement

Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.

Sales

Clarify Health

MARCH 22, 2024

While healthcare price transparency regulations aim to empower patients and promote competition in the market, providers face significant challenges in implementing and complying with these requirements effectively. Implementing price transparency requires a robust technology infrastructure to collect, store, update, and disseminate pricing information effectively.

Healthcare Provider 52

Healthcare Provider Healthcare Healthcare Competition 52

Pharmacy Times

MARCH 22, 2024

Bempedoic acid (Nexletol; Esperion) and bempedoic acid and ezetimibe (Nexlizet; Esperion) are the only LDL-C lowering non-statin drugs indicated for primary prevention patients.

FDA 60

FDA Patients 60

PharmaTech

MARCH 22, 2024

The company is recalling one lot of the product because of the potential presence of silicone particulates.

Pharmaceutical 52

Pharmaceutical 52

Pharmacy Times

MARCH 22, 2024

Pharmacists can educate patients on current clinical evidence of cannabis’s therapeutic benefit, as well as cannabis’s complexities, risks, and potential adverse effects.

Patients 55

Patients Education 55

Advertisement

Distribution

PM360

MARCH 22, 2024

The effective ongoing incorporation of Artificial Intelligence (AI) has emerged as a pivotal force within the pharmaceutical sector, reshaping the traditional paradigms of drug discovery, development, and commercialization. However, it’s also charting new waters for consultancies supporting the sector. How do AI and strategy consultants fit together?

Consulting 52

Consulting Training Recruitment Physicians 52

Pharmaceutical Technology

MARCH 22, 2024

Lisata Therapeutics announced a rare pediatric drug designation for LSTA1, which is being studied in several early to mid-stage clinical studies.

52

52

PM360

MARCH 22, 2024

Exploring the role of patient advocacy groups and clinical trials while discussing the challenges faced, and how artificial intelligence and modern methods revolutionize the landscape. Despite the unique traits exhibited by approximately 11,000 rare diseases (RD), patients commonly face challenges due to the diseases’ low prevalence, including feelings of isolation and navigating overwhelming information about their condition 1.

Patients 52

Patients Recruitment Ethics Government 52

Pharmaceutical Technology

MARCH 22, 2024

The FDA has approved Duvyzat for Duchenne muscular dystrophy patients aged six years and above.

FDA 52

FDA Patients 52

Advertisement

Are your sellers unsure about using AI in their day-to-day workflows? Or are they eager to try but uncertain where to start? They might be asking: Which tasks are best suited for AI? How will using AI affect my relationship with my customers? With so many tools available, which ones are the most useful to me? To help answer these and other common questions about using AI during the sales cycle, we surveyed B2B sellers who were early adopters to get their insight and advice about how to use gen A

Sales